We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

51 hedge funds and large institutions have $198M invested in T2 Biosystems, Inc in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 2

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

61% more capital invested

Capital invested by funds: $123M → $198M (+$75.4M)

24% more funds holding

Funds holding: 4151 (+10)

Holders
51
Holders Change
+10
Holders Change %
+24.39%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
13
Increased
19
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TTOO Hedge Fund Activity: Q4 2015 in Review

51 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2015, worth a combined $198M — up 61% from $123M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TTOO positions and 3 closed out — a net gain of 10 holders — while 19 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $7.55M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $7.66M.

  • 51 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2015, up from 41 in Q3 2015.
  • Funds reported $198M of T2 Biosystems, Inc stock for Q4 2015, up 61% quarter-over-quarter.
  • 13 funds opened new T2 Biosystems, Inc positions in Q4 2015 and 3 closed out, a net change of +10 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2015 was Goldman Sachs, an estimated $7.55M added.
  • The largest T2 Biosystems, Inc seller in Q4 2015 was Gilder Gagnon Howe & Co, an estimated $7.66M sold.

Based on aggregated 13F filings for Q4 2015.